TELA Bio Announces 20% Workforce Reduction; CFO Steps Down

What Happened TELA Bio, Inc. announced a strategic cost-reduction plan on August 28, 2026, to lower operating expenses and preserve capital, primarily by reducing headcount. The company will cut its workforce from 201 full-time employees to about 160 (approximately 20%), with the reductions expected to be substantially completed during the third quarter of 2026. Separately, effective August 31, 2026, Roberto Cuca stepped down as CFO, COO, Corporate Secretary and principal financial officer; Heather Getz was appointed as the company’s principal financial officer.

Key Details

• Workforce cut: ~20%, from 201 to ~160 full-time employees; substantially completed in Q3 2026.
• Estimated charges: approximately $1.5 million, largely severance and other employee-related costs; substantially all expected to be cash expenditures in Q3 2026.
• Executive change: Roberto Cuca’s departure treated as a termination without cause under his employment agreement; a separation agreement is expected and will be filed with the Q3 2026 Form 10-Q.
• Disclosure: Company issued a press release on August 31, 2026 (furnished as Exhibit 99.1).

Why It Matters The workforce reduction and associated $1.5M charge are intended to lower near-term operating costs and conserve cash as TELA focuses on improving product sales and future revenue growth. For investors, the cost savings could help extend the company’s runway, but the reductions and executive change could also affect operations and financial reporting in the near term. The company notes estimates may change and additional charges could arise as the plan is implemented.